Leutinizing Hormone
Leutinizing Hormone
Categories
- Chemistry
- Health Assessment and Safety
General Information
Name | Information |
---|---|
Code: | T183 |
Matrix: | Serum |
Application: | Insurance Risk Assessment, Wellness |
Turnaround Time: | Daily |
Analytical - Method: | Sandwich principle |
Reportable - Test Results Type: | Quantitative |
Units - Conventional: | mIU/mL |
Specimen Information
Name | Information |
---|---|
Minimum Volume: | 50 µL required |
Preferred Volume: | 500 µL preferred |
Rejection Criteria: | Improper labeling, improper sample handling, and wrong sample type. |
Collection Instructions: | See “Blood Collection” |
Collection Patient Preparation: | NA |
Container: | Serum Collected using standard sampling tubes or tubes containing separating gel. Li-, Na-, NH4+-heparin, K3-EDTA and sodium fluoride/potassium oxalate plasma. When sodium citrate is used, the results must be corrected by +10%. |